Siemens, Northwestern Medicine Team Up on Cancer Care

Northwestern Medicine and Siemens Healthineers have forged a multi-year strategic collaboration to redefine diagnostics and cancer care. Specifically, the partnership aims to accelerate innovation in imaging, theranostics, interventional radiology, and radiation oncology to deliver a new standard of precision care. 

“This alliance represents our commitment to innovation in imaging and cancer care,” said James Carr, M.D., chair, Department of Radiology, Northwestern Medicine and professor of Radiology, Medicine, and Biomedical Engineering, Northwestern University Feinberg School of Medicine. “By integrating Siemens Healthineers’ advanced technologies with Northwestern Medicine’s clinical expertise, we can create a future where patients benefit from faster diagnoses, more personalized treatments, and transformative outcomes across the continuum of care.” 

Bringing together advanced technologies and streamlined workflows, Northwestern Medicine and Siemens Healthineers are attempting to set a new standard for compassionate, effective cancer care. Employing state-of-the-art technology, software, and advisory services, Northwestern Medicine and Siemens Healthineers will establish a global center of excellence in theranostics, a personalized approach that uses radiopharmaceuticals for cancer diagnosis and treatment. 

Areas of focus include: 

• Patient journey transformation: Reimagining oncology care pathways to enhance the patient experience while increasing efficiency and improving outcomes. 
• Theranostics leadership: Establishing a global center of excellence for radiopharmaceutical-based diagnosis and treatment. 
• Interventional radiology innovation: Advancing interventional MRI and other minimally invasive procedures while enhancing collaborations with leading device companies. 
• Radiation oncology optimization: AI-enhanced workflows for faster, more accurate treatment planning and delivery. 

“With more than 20 years of research collaboration, we have in Northwestern Medicine an innovative collaborator dedicated to making important strides in cancer care, improving both care quality and offering access to care closer to patients’ homes,” stated John Kowal, president and head of the Americas at Siemens Healthineers.

Siemens Healthineers is a global provider of healthcare equipment, solutions, and services, with activities in more than 180 countries and direct representation in more than 70. The group comprises Siemens Healthineers AG, listed as SHL in Frankfurt, Germany, and its subsidiaries. The company is principally active in imaging, diagnostics, cancer care, and minimally invasive therapies, augmented by digital technology and artificial intelligence. In fiscal 2025, which ended on Sept. 30, 2025, Siemens Healthineers employed approximately 74,000 workers worldwide and generated €23.4 billion in revenue.